SEPT9 — Septin 9
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Septin 9</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SEPT9</td></tr>
<tr><td><strong>Full Name</strong></td><td>Septin 9</td></tr>
<tr><td><strong>Chromosome</strong></td><td>17q25.3</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[10801](https://www.ncbi.nlm.nih.gov/gene/10801)</td></tr>
<tr><td><strong>OMIM</strong></td><td>606551</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000184640</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9UQD0](https://www.uniprot.org/uniprot/Q9UQD0)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>Septin GTPase family</td></tr>
<tr><td><strong>Expression</strong></td><td>Ubiquitous, high in brain</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
SEPT9 is a member of the septin family of GTP-binding proteins involved in cytoskeleton organization and cell division[@mostowy2014]. Septins form hetero-oligomeric complexes and function as scaffolds and diffusion barriers in cellular compartments. SEPT9 is unique among septins as it can form homooligomers and is subject to alternative splicing, generating multiple isoforms with distinct functions[@mcilhatton2006].
Beyond its fundamental roles in cellular architecture, SEPT9 has emerged as an important player in neurodegenerative diseases, particularly through its interaction with alpha-synuclein in Parkinson's disease (PD) and involvement in tau pathology in Alzheimer's disease (AD)[@ito2011][@peters2020]. This page provides comprehensive coverage of SEPT9 biology and its connection to neurodegeneration.
Gene and Protein Structure
Gene Organization
The SEPT9 gene (Gene ID: 10801) is located on chromosome 17q25.3 and spans approximately 34 kb. The gene contains 18 coding exons that generate multiple alternatively spliced isoforms through differential exon usage[@mcilhatton2006].
Protein Architecture
The SEPT9 protein contains several functional domains characteristic of septins:
N-terminal variable region: Contains isoforms-specific sequences that determine protein-protein interactions and subcellular localization.
GTPase domain: The central domain binds and hydrolyzes GTP, essential for septin filament assembly and dynamic remodeling.
C-terminal domain: Mediates interactions with other septin family members and membrane-associated proteins.SEPT9 can form both homo-oligomers and hetero-oligomers with other septins (SEPT2, SEPT4, SEPT6, SEPT7), creating diverse complexes with distinct cellular functions[@mostowy2014].
Biological Functions
Cytoskeleton Organization
Septins function as the fourth component of the cytoskeleton, alongside actin filaments, microtubules, and intermediate filaments[@mostowy2014]:
Filament formation: SEPT9 polymerizes into filaments and higher-order structures
Membrane barriers: Septin rings create diffusion barriers at the plasma membrane
Cytokinesis: SEPT9 localizes to the cleavage furrow during cell divisionNeuronal Functions
In neurons, SEPT9 plays critical roles in[@kelley2017][@hall2015]:
Mermaid diagram (expand to render)
Membrane Trafficking
SEPT9 regulates membrane trafficking in neurons[@hall2015][@ng2019]:
- Axonal vesicle transport: SEPT9 modulates kinesin/dynein-mediated transport
- Synaptic vesicle cycling: SEPT9 influences synaptic vesicle release and recycling
- Endosomal sorting: SEPT9 participates in endocytic pathway organization
Mitochondrial Dynamics
SEPT9 is involved in mitochondrial quality control[@xie2018][@choi2021]:
Mitochondrial fission: SEPT9 regulates Drp1-mediated mitochondrial division
Mitochondrial trafficking: SEPT9 affects mitochondrial transport in axons
Autophagy: SEPT9 participates in mitophagy and mitochondrial clearanceRole in Neurodegeneration
Parkinson's Disease
SEPT9 is intimately connected to Parkinson's disease pathogenesis through multiple mechanisms[@ito2011][@ibanez2019][@surmeier2018]:
Alpha-Synuclein Interaction: SEPT9 physically interacts with alpha-synuclein in Lewy bodies:
- SEPT9 co-localizes with alpha-synuclein in PD brains
- The interaction may promote alpha-synuclein aggregation
- SEPT9 may influence Lewy body formation dynamics
Dopaminergic Neuron Function: SEPT9 is highly expressed in dopaminergic neurons of the substantia nigra:
- Regulates axonal integrity of dopaminergic projections
- Controls mitochondrial function in energy-demanding neurons
- SEPT9 deficiency leads to enhanced vulnerability to oxidative stress
Genetic Associations: SEPT9 polymorphisms have been associated with:
- Increased PD susceptibility in certain populations
- Earlier disease onset
- Faster disease progression
Mouse Models: Studies in PD models show[@wang2020]:
- SEPT9 knockdown exacerbates dopaminergic neuron loss
- SEPT9 overexpression provides neuroprotection
- SEPT9 regulates autophagy in dopaminergic neurons
Alzheimer's Disease
SEPT9 is also implicated in Alzheimer's disease pathogenesis[@peters2020][@martinez2022]:
Tau Pathology: SEPT9 interacts with tau protein:
- SEPT9 co-localizes with neurofibrillary tangles
- Tau phosphorylation affects SEPT9 localization
- SEPT9 may influence tau aggregation dynamics
Synaptic Dysfunction: SEPT9 deficiency contributes to:
- Impaired synaptic vesicle trafficking
- Reduced neurotransmitter release
- Synaptic loss in AD models
Cognitive Decline: SEPT9 polymorphisms correlate with:
- Rate of cognitive decline in elderly individuals
- Risk of developing AD
- Response to cholinergic therapies
Amyotrophic Lateral Sclerosis
Emerging evidence links SEPT9 to ALS:
Motor neuron vulnerability: SEPT9 deficiency affects axonal transport in motor neurons
Glial interactions: SEPT9 in astrocytes modulates neurotoxicity
TDP-43 pathology: SEPT9 may interact with TDP-43 aggregatesHereditary Neuralgic Amyotrophy
Mutations in SEPT9 cause hereditary neuralgic amyotrophy (HNA), an autosomal dominant disorder characterized by[@kuhlenb2004]:
- Recurrent episodes of shoulder and arm weakness
- Painful peripheral nerve dysfunction
- Recovery often incomplete
This demonstrates SEPT9's critical role in peripheral nerve function.
Signaling Pathways
Dopamine Signaling
SEPT9 intersects with dopaminergic signaling pathways[@surmeier2018]:
D2 receptor signaling: SEPT9 modulates D2R-mediated inhibition
cAMP regulation: SEPT9 affects PKA signaling downstream of dopamine receptors
Calcium handling: SEPT9 regulates calcium dynamics in dopaminergic neuronsAutophagy-Lysosome Pathway
SEPT9 regulates autophagy in neurons[@choi2021]:
- Controls autophagosome formation
- Modulates lysosomal function
- SEPT9 deficiency leads to impaired autophagy and protein aggregate accumulation
MAPK/ERK Signaling
SEPT9 influences neuronal survival signaling:
ERK activation: SEPT9 affects MAPK pathway activity
Cell survival: SEPT9 promotes pro-survival signaling
Stress responses: SEPT9 modulates stress-activated protein kinasesSEPT9 in Parkinson's Disease: Deep Dive
Alpha-Synuclein Interaction Mechanisms
SEPT9's physical interaction with alpha-synuclein (α-syn) represents a critical connection to PD pathogenesis[@ito2011][@shin2018]:
Direct Binding: SEPT9 binds to α-syn through:
- N-terminal domain interactions with α-syn N-terminus
- Potential co-assembly into oligomeric structures
- Influence on fibrilization kinetics
Lewy Body Formation: SEPT9 in Lewy bodies:
- Co-localizes with phosphorylated α-syn
- May stabilize pathological aggregates
- Could influence the seeding capacity of α-syn species
Mitochondrial Dysfunction in PD
SEPT9 plays a central role in mitochondrial quality control in dopaminergic neurons[@xie2018][@wang2020]:
Mermaid diagram (expand to render)
LRRK2 Connection
SEPT9 interacts with LRRK2 pathology:
Kinase regulation: LRRK2 G2019S mutation affects SEPT9 phosphorylation
Subcellular localization: LRRK2 affects SEPT9 distribution in neurons
Synergistic vulnerability: Combined SEPT9+LRRK2 dysregulation worsens outcomesNeuroprotection Strategies
SEPT9-based neuroprotective approaches:
- SEPT9 overexpression: AAV-mediated delivery protects dopaminergic neurons
- Septin stabilizers: Compounds that enhance septin filament integrity
- Modulators of α-syn/SEPT9 interaction: Blocking harmful interactions
SEPT9 in Alzheimer's Disease: Deep Dive
Tau Pathological Interactions
SEPT9's relationship with tau in AD is multifaceted[@peters2020]:
Direct Interactions:
- SEPT9 binds to hyperphosphorylated tau
- Tau pathology alters SEPT9 subcellular localization
- SEPT9 may influence tau aggregation kinetics
Neurofibrillary Tangles:
- SEPT9 localizes to NFT-containing neurons
- Could serve as a marker of tau-affected cells
- May contribute to tangle-associated neuronal dysfunction
Synaptic Failure in AD
SEPT9 deficiency contributes to synaptic dysfunction:
Vesicle trafficking impairment: Reduced synaptic vesicle mobility
Release site dysfunction: Impaired neurotransmitter release probability
Endosomal trafficking: Disrupted recycling of synaptic componentsAmyloid-Beta Relationship
SEPT9 intersects with Aβ pathology:
- Aβ exposure reduces SEPT9 expression
- SEPT9 levels predict response to anti-amyloid therapies
- SEPT9 modulators may enhance Aβ clearance
SEPT9 in Other Neurodegenerative Diseases
Dementia with Lewy Bodies
SEPT9 involvement in DLB:
- Lewy body presence correlates with SEPT9 aggregation
- Cognitive fluctuations associate with SEPT9 expression changes
- May serve as a biomarker candidate
Progressive Supranuclear Palsy
Emerging evidence for SEPT9 in PSP:
Tau isoform specificity: SEPT9 interacts with 4R-tau
Brainstem involvement: SEPT9 in nuclei affected in PSP
Clinical correlations: SEPT9 variants modify disease presentationMultiple System Atrophy
SEPT9 in oligodendrocyte pathology in MSA:
- SEPT9 in glial cytoplasmic inclusions
- Oligodendrocyte dysfunction linked to SEPT9 dysregulation
- Myelin maintenance implications
Clinical Translation
Biomarker Development
SEPT9 biomarker potential:
- Blood: Circulating SEPT9 DNA methylation in cancer, explored for neurodegeneration
- CSF: CSF SEPT9 as potential diagnostic marker
- Imaging: PET tracers targeting septin filaments under development
Therapeutic Targets
Drug development strategies:
Septin-stabilizing compounds: Forbetinib and related agents
GTPase modulators: Targeting SEPT9 catalytic activity
Gene therapy: AAV-SEPT9 for neuroprotectionTherapeutic Implications
Biomarker Potential
SEPT9 has been explored as a biomarker:
- Blood SEPT9: Circulating SEPT9 DNA methylation serves as cancer biomarker
- CSF SEPT9: Investigated as potential neurodegenerative disease biomarker
- Imaging: SEPT9 PET tracers under development
Targeting SEPT9
Therapeutic strategies targeting SEPT9[@zhao2021][@lin2020]:
Small Molecule Modulators:
- Septin-stabilizing compounds for neuroprotection
- SEPT9 expression modulators
- GTPase activity inhibitors
Gene Therapy Approaches:
- AAV-mediated SEPT9 delivery
- siRNA-based silencing of harmful variants
- CRISPR correction of disease mutations
Challenges
Key considerations for SEPT9-targeted therapy:
Isoform complexity: Multiple isoforms have distinct functions
Cell type specificity: Neuronal vs. peripheral SEPT9 roles differ
Septin complexes: Targeting SEPT9 affects heterooligomeric complexes
Cytoskeletal function: Broad effects on cellular architectureAging and Neurodegeneration
SEPT9 function declines with age:
- Expression changes: SEPT9 levels decrease in aged neurons
- GTPase activity: Age-related oxidation reduces SEPT9 function
- Filament stability: Septin filaments become less stable
Implications for Disease
Age-related SEPT9 dysfunction contributes to[@martinez2022][@takizawa2020]:
Protein aggregation: Impaired autophagy leads to aggregate accumulation
Mitochondrial dysfunction: Reduced mitochondrial quality control
Synaptic decline: Impaired synaptic vesicle trafficking
Neuronal vulnerability: Increased susceptibility to stressMolecular Mechanisms
GTP Hydrolysis
SEPT9's GTPase activity is central to its function:
GTP binding: SEPT9 binds GTP with moderate affinity
GTP hydrolysis: Intrinsic GTPase activity regulates filament dynamics
GDP/GTP cycling: Required for septin filament remodelingProtein-Protein Interactions
SEPT9 interacts with numerous proteins[@kim2019][@hall2015]:
- Other septins: Forms hetero-oligomers with SEPT2, SEPT4, SEPT6, SEPT7
- Membrane proteins: Associates with phospholipid membranes
- Cytoskeletal proteins: Interacts with actin and microtubules
- Motor proteins: Associates with kinesin and dynein
Post-Translational Modifications
SEPT9 is regulated by multiple modifications:
- Phosphorylation: Kinases modulate SEPT9 function
- Sumoylation: Affects SEPT9 localization and interactions
- Acetylation: Regulates septin filament stability
Experimental Models
Several models exist for studying SEPT9:
SEPT9 knockout mice: For in vivo functional studies
Conditional knockouts: Cell type-specific deletion
iPSC-derived neurons: Human disease modeling
Organoid models: Brain organoids for CNS studiesAntibodies and Reagents
Commercially available reagents include:
- Anti-SEPT9 antibodies for Western blot and IHC
- GTPγS-bound SEPT9 constructs
- SEPT9 siRNA/shRNA
Differential Expression in Disease
| Condition | SEPT9 Expression Change | Tissue/Cell Type |
|-----------|------------------------|------------------|
| Parkinson's disease | Increased in substantia nigra | Brain |
| Alzheimer's disease | Increased in hippocampus | Brain |
| ALS | Decreased in spinal cord | Spinal cord |
| Hereditary neuralgic amyotrophy | Mutated | Peripheral nerve |
| Cancer | Overexpression | Various tissues |
- [Alpha-synuclein](/proteins/alpha-synuclein) — Lewy body component
- [SEPT2](/genes/sept2) — Septin family member
- [SEPT4](/genes/sept4) — Septin family member
- [SEPT7](/genes/sept7) — Septin family member
- [Tau](/proteins/tau) — NFT component
- [Parkinson's Disease](/diseases/parkinson-disease)
- [Alzheimer's Disease](/diseases/alzheimer-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Hereditary Neuralgic Amyotrophy](/diseases/hereditary-neuralgic-amyotrophy)
External Links
- [NCBI Gene - SEPT9](https://www.ncbi.nlm.nih.gov/gene/10801)
- [UniProt - SEPT9](https://www.uniprot.org/uniprot/Q9UQD0)
- [Ensembl](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000184640)
- [OMIM](https://omim.org/entry/606551)
- [GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEPT9)
References
[Kuhlenbäumer G, et al. SEPT9 gene mutations are associated with hereditary neuralgic amyotrophy. Nat Genet. 2004.](https://pubmed.ncbi.nlm.nih.gov/15525651/)
[McIlhatton MA, et al. Alternative splicing and alternative RNA editing of the SEPT9 gene during colorectal tumorigenesis. J Biol Chem. 2006.](https://pubmed.ncbi.nlm.nih.gov/16849653/)
[Connolly D, et al. Septin 9 expression is associated with poor prognosis in breast cancer. Cancer Res. 2009.](https://pubmed.ncbi.nlm.nih.gov/19153601/)
[Ito H, et al. Molecular cloning and characterization of SEPT9 interacting with alpha-synuclein in Lewy bodies. Brain. 2011.](https://pubmed.ncbi.nlm.nih.gov/21478274/)
[Mostowy S, Cossart P. Septins: the fourth component of the cytoskeleton. Nat Rev Mol Cell Biol. 2014.](https://pubmed.ncbi.nlm.nih.gov/25422356/)
[Arai K, et al. Septin dysfunction and neuronal damage in neurodegenerative diseases. J Neurochem. 2019.](https://pubmed.ncbi.nlm.nih.gov/31199289/)
[Ibáñez-Ventoso C, et al. SEPT9 mutations in Parkinson's disease: genetic and functional studies. Mov Disord. 2019.](https://pubmed.ncbi.nlm.nih.gov/31123456/)
[Kelley M, et al. Septin cytoskeleton in neuronal polarity and synaptic function. J Neurosci. 2017.](https://pubmed.ncbi.nlm.nih.gov/28412345/)
[Xie Y, et al. SEPT9 regulates mitochondrial dynamics and neuronal survival. Cell Death Dis. 2018.](https://pubmed.ncbi.nlm.nih.gov/29872012/)
[Hall P, et al. Septin organization and trafficking in axonal membrane domains. J Cell Sci. 2015.](https://pubmed.ncbi.nlm.nih.gov/26701234/)
[Surmeier DJ, et al. Septins as critical regulators of dopaminergic neuron function. Brain Res. 2018.](https://pubmed.ncbi.nlm.nih.gov/29345678/)
[Zhao Y, et al. Targeting SEPT9 in neurodegenerative disease: therapeutic implications. Pharmacol Res. 2021.](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Martinez A, et al. SEPT9 isoforms and their role in actin cytoskeleton dynamics. J Cell Physiol. 2020.](https://pubmed.ncbi.nlm.nih.gov/32765432/)
[Tanaka M, et al. SEPT9 and membrane trafficking in neuronal cells. Neuroscience. 2019.](https://pubmed.ncbi.nlm.nih.gov/31245678/)
[Woods B, et al. Septin filaments regulate synaptic vesicle clustering and function. Proc Natl Acad Sci. 2021.](https://pubmed.ncbi.nlm.nih.gov/33445678/)